Phase 2 Study of ADX-038 in Complement-Mediated Kidney Disease

ADARx Clinical Site, Doral, Florida, United States

ADARx Clinical Site, Miami, Florida, United States

ADARx Clinical Site, Pembroke Pines, Florida, United States

ADARx Clinical Site, Iowa City, Iowa, United States

ADARx Clinical Site, Shreveport, Louisiana, United States

ADARx Clinical Site, Shelby, Michigan, United States

ADARx Clinical Site, Great Neck, New York, United States

ADARx Clinical Site, Columbus, Ohio, United States

ADARx Clinical Site, Dakota Dunes, South Dakota, United States

ADARx Clinical Site, Dallas, Texas, United States

ADARx Clinical Site, Houston, Texas, United States

ADARx Clinical Site, Liverpool, New South Wales, Australia

ADARx Clinical Site, Wollongong, New South Wales, Australia

ADARx Clinical Site, Sydney, Australia

ADARx Clinical Site, Woolloongabba, Australia

ADARx Clinical Site, Hong Kong, Hong Kong

ADARx Clinical Site, Shatin, Hong Kong

ADARx Clinical Site, Wŏnju, Gangwon-do, South Korea

ADARx Clinical Site, Cheonan, South Korea

ADARx Clinical Site, Daegu, South Korea

ADARx Clinical Site, Gyeonggi-do, South Korea

ADARx Clinical Site, Seoul, South Korea

ADARx Clinical Site, Seoul, South Korea

ADARx Clinical Site, Seoul, South Korea

ADARx Clinical Site, Seoul, South Korea

ADARx Clinical Site, Barcelona, Spain

ADARx Clinical Site, Madrid, Spain

ADARx Clinical Site, Seville, Spain

ADARx Clinical Site, Newcastle upon Tyne, United Kingdom